Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
The Honest Company | HNST | Nov 4, 2024 | 3.84 | +2.13 |
The Intergroup | INTG | Nov 4, 2024 | 14.53 | +0.17 |
The J.M Smucker Company | SJM | Nov 4, 2024 | 113.69 | +0.68 |
The Joint | JYNT | Nov 4, 2024 | 11.10 | +0.18 |
The Marygold Companies | MGLD | Nov 4, 2024 | 1.25 | +8.09 |
The ODP | ODP | Nov 4, 2024 | 31.16 | -1.05 |
The OLB Group | OLB | Nov 4, 2024 | 1.85 | -7.96 |
The Oncology Institute | TOI | Nov 4, 2024 | 0.28 | -6.64 |
The ONE Group Hospitality | STKS | Nov 4, 2024 | 3.43 | +0.59 |
The Pennant Group | PNTG | Nov 4, 2024 | 32.38 | -0.34 |
The Real Brokerage | REAX | Nov 4, 2024 | 5.30 | -0.56 |
The Real Estate Select Sector SPDR Fund | XLRE | Nov 4, 2024 | 43.22 | +1.12 |
The RealReal | REAL | Nov 4, 2024 | 3.05 | +2.01 |
The RMR Group A | RMR | Nov 4, 2024 | 23.52 | -0.30 |
The Shyft Group | SHYF | Nov 4, 2024 | 13.20 | +0.69 |
The Trade Desk A | TTD | Nov 4, 2024 | 118.27 | -0.77 |
The9 ADR | NCTY | Nov 4, 2024 | 8.18 | -0.73 |
TherapeuticsMD | TXMD | Nov 4, 2024 | 1.55 | +0.06 |
Theratechnologies | THTX | Nov 4, 2024 | 1.19 | -2.46 |
Theravance Biopharma | TBPH | Nov 4, 2024 | 8.21 | -0.85 |
Theriva Biologics | TOVX | Nov 4, 2024 | 2.07 | +4.02 |
Thermo Fisher Scientific | TMO | Nov 4, 2024 | 555.47 | -0.44 |
Thermon Group | THR | Nov 4, 2024 | 26.22 | -0.72 |
Third Coast Bancshares | TCBX | Nov 4, 2024 | 32.19 | -1.05 |
Third Harmonic | THRD | Nov 4, 2024 | 12.11 | -15.53 |
Thomson Reuters | TRI | Nov 4, 2024 | 165.02 | +0.15 |
Thor Industries | THO | Nov 4, 2024 | 104.98 | +0.38 |
Thornburg Income Builder Opportunities Fund | TBLD | Nov 4, 2024 | 17.19 | -0.69 |
Thoughtworks | TWKS | Nov 4, 2024 | 4.46 | 0.00 |
ThredUp A | TDUP | Nov 4, 2024 | 0.53 | -4.52 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.